Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites

Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites

BackgroundLingguizhugan decoction is a traditional Chinese medicine prescription that has been used to improve non-alcoholic fatty liver disease and its progressive form, non-alcoholic steatohepatitis (NASH). However, the anti-NASH effects and underlying mechanisms of Lingguizhugan decoction remain...

Full description

Bibliographic Details
Main Authors:	Mingzhe Zhu, Xue Wang, Kai Wang, Zhiqiang Zhao, Yanqi Dang, Guang Ji, Fenghua Li, Wenjun Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	Lingguizhugan decoction NASH MCD diet gut microbiota metabolomics
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2023.1066053/full

Similar Items

Effect of Lingguizhugan decoction in activating fat mobilization in obesity
by: Yubin YANG, et al.
Published: (2022-03-01)

Lingguizhugan Decoction Targets Intestinal Microbiota and Metabolites to Reduce Insulin Resistance in High-Fat Diet Rats
by: Ning Y, et al.
Published: (2022-08-01)

Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages
by: Lin Cao, et al.
Published: (2022-01-01)

Lingguizhugan decoction alleviates obesity in rats on a high-fat diet through the regulation of lipid metabolism and intestinal microbiota
by: Wenjing Huang, et al.
Published: (2024-11-01)

Lingguizhugan decoction enhances autophagy of Alzheimer’s disease via regulating the mTOR/ p70s6K pathway in vivo and in vitro
by: Xiaojing Chen, et al.
Published: (2025-01-01)

Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial
by: Jingjuan Xu, et al.
Published: (2020-06-01)

Supplementation with Lycium chinense fruit extract attenuates methionine choline-deficient diet-induced steatohepatitis in mice
by: Ui-Jin Bae, et al.
Published: (2017-04-01)

SPP1 and CXCL9 Promote Non-alcoholic Steatohepatitis Progression Based on Bioinformatics Analysis and Experimental Studies
by: Wen Wang, et al.
Published: (2022-04-01)

Lingguizhugan oral solution alleviates MASLD by regulating bile acids metabolism and the gut microbiota through activating FXR/TGR5 signaling pathways
by: Jiahua Wang, et al.
Published: (2024-08-01)

Lipocalin 2 induces neuroinflammation and blood-brain barrier dysfunction through liver-brain axis in murine model of nonalcoholic steatohepatitis
by: Ayan Mondal, et al.
Published: (2020-07-01)

Decoction regulating phytochemicals’ micromorphology changes and anti-inflammation activity enhancements originated from herb medicine supermolecules
by: Luping Yang, et al.
Published: (2024-01-01)

Small molecule-driven LKB1 deacetylation is responsible for the inhibition of hepatic lipid response in NAFLD
by: Weiwei Qin, et al.
Published: (2025-02-01)

Buzhongyiqi Decoction Protects Against Loperamide-Induced Constipation by Regulating the Arachidonic Acid Pathway in Rats
by: Wan-Jun Ju, et al.
Published: (2020-04-01)

Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
by: Yifei Lu, et al.
Published: (2022-09-01)

Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease
by: Jarren R. Oates, et al.
Published: (2023-02-01)

Gan-jiang-ling-zhu decoction improves steatohepatitis by regulating gut microbiota-mediated 12-tridecenoic acid inhibition
by: Ruohui Xu, et al.
Published: (2024-08-01)

Jia-Wei-Si-Miao-Yong-An decoction modulates intestinal flora and metabolites in acute coronary syndrome model
by: Ning Zhao, et al.
Published: (2023-01-01)

Integrated gut microbiome and metabolomic analyses elucidate the therapeutic mechanisms of Suanzaoren decoction in insomnia and depression models
by: Hongxiong Zhang, et al.
Published: (2024-10-01)

Mechanism of Wuzhuyu decoction on alcohol-induced gastric ulcers using integrated network analysis and metabolomics
by: Xin Wang, et al.
Published: (2024-01-01)

Gut Microbiota and Related Metabolites Were Disturbed in Ulcerative Colitis and Partly Restored After Mesalamine Treatment
by: Liang Dai, et al.
Published: (2021-01-01)

Shizao decoction for cirrhotic ascites: assessing potential targets based on network analysis combined with pharmacokinetics and metabolomics
by: Wenjing Li, et al.
Published: (2024-01-01)

Reversed role of CD36 deficiency in high-fat diet or methionine/choline-deficient diet-induced hepatic steatosis and steatohepatitis
by: Wenya Zhu, et al.
Published: (2025-03-01)

Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl4-induced hepatic fibrosis
by: Xue Li, et al.
Published: (2024-03-01)

A metabolomic study of Baihe Zhimu decoction in a rat model of depression
by: LIU Zhirui, et al.
Published: (2019-10-01)

Modulation of the biological network of lumbar spinal stenosis by Tongdu Huoxue Decoction based on clinical metabolomics
by: Luhong Ji, et al.
Published: (2023-03-01)

New Clinical Application of Chaihu Decoction
by: Bo Huang, et al.
Published: (2022-09-01)

Metabolomics Profiles Reveal the Efficacy of Wuzhuyu Decoction on Patients with Chronic Non-Atrophic Gastritis
by: Hu Q, et al.
Published: (2023-11-01)

GCTOF-MS Combined LC-QTRAP-MS/MS Reveals Metabolic Difference Between Osteoarthritis and Osteoporotic Osteoarthritis and the Intervention Effect of Erxian Decoction
by: Zhenyuan Ma, et al.
Published: (2022-07-01)

Effect of sanhuanghuoxue decoction on the treatment of chronic renal failure
by: Qiang Wu, et al.
Published: (2016-03-01)

Ganmaidazao decoction alleviated cognitive impairment on Alzheimer's disease rats by regulating gut microbiota and their corresponding metabolites
by: Meirong Cui, et al.
Published: (2023-05-01)

Exploration of the mechanism of Qi-Xian decoction in asthmatic mice using metabolomics combined with network pharmacology
by: Yuhua Lin, et al.
Published: (2023-12-01)

Gancao Xiexin Decoction Ameliorates Ulcerative Colitis in Mice via Modulating Gut Microbiota and Metabolites
by: Luo YT, et al.
Published: (2022-05-01)

Effect of Yinlai Decoction on the metabolic pathways in the lung of high-calorie diet-induced pneumonia rats
by: Fuyang Xian, et al.
Published: (2021-01-01)

Yangyinqingfei decoction attenuates PM2.5-induced lung injury by enhancing arachidonic acid metabolism
by: Chunlan Tang, et al.
Published: (2022-11-01)

Integrated network pharmacology and metabolomics to study the potential mechanism of Jiawei Yinchenhao decoction in chronic hepatitis B
by: Xinyi Xu, et al.
Published: (2024-08-01)

Integrated transcriptomic and metabolomic profiles reveal the protective mechanism of modified Danggui Buxue decoction on radiation-induced leukopenia in mice
by: Wei Chen, et al.
Published: (2023-08-01)

Insights into the molecular mechanisms of Huangqi decoction on liver fibrosis via computational systems pharmacology approaches
by: Biting Wang, et al.
Published: (2021-07-01)

Non-Alcoholic Steatohepatitis Patient Characterization and Real-World Management Approaches in Italy
by: Bugianesi E, et al.
Published: (2024-10-01)

Microbiome Metabolomic Analysis of the Anxiolytic Effect of Baihe Dihuang Decoction in a Rat Model of Chronic Restraint Stress
by: Tang L, et al.
Published: (2024-06-01)

Phytophotodermatitis due to chinese herbal medicine decoction
by: Ruzhi Zhang, et al.
Published: (2011-01-01)